Navigating Molina Healthcare Xarelto Prior Authorization

Molina Healthcare's General Prior Authorization Framework

Molina Healthcare utilizes a structured prior authorization process across its various health plans, including Medicaid, Medicare, and Marketplace products. While specific forms and portals may vary by state or plan, the core requirement for medical necessity documentation remains consistent. Revenue cycle teams must identify the correct Molina plan and associated PA submission channels to avoid initial processing delays.

Xarelto Specifics: Indications and Clinical Criteria

Xarelto is indicated for several conditions, including the prevention of stroke and systemic embolism in non-valvular atrial fibrillation (NVAF), treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and DVT/PE prophylaxis following orthopedic surgery. Molina Healthcare's clinical criteria for Xarelto typically align with FDA-approved indications and may incorporate guidelines from sources like MCG Health or InterQual. Documentation must clearly support the prescribed indication and demonstrate the patient's eligibility based on these criteria.

Submission Pathways for Molina Xarelto PAs

Molina Healthcare offers multiple methods for prior authorization submission. These include proprietary provider portals, general third-party portals like Availity or CoverMyMeds, fax, and electronic prior authorization (ePA) via NCPDP SCRIPT standards. The most efficient method often depends on the clinic's EMR integration capabilities and the specific Molina plan. Utilizing ePA can significantly reduce manual data entry and improve turnaround times.

Required Documentation for Xarelto Approval

A complete submission package is critical for Molina Xarelto prior authorization. Inadequate clinical detail or missing information is a primary driver of initial denials. Teams must ensure all necessary components are systematically gathered and submitted with the initial request.

Key Documentation Components:

• Patient demographics and Molina member ID.
• Prescriber information, including NPI.
• Specific Xarelto dosage, frequency, and duration of therapy.
• Relevant ICD-10 diagnosis codes supporting the indication (e.g., I48.91 for NVAF, I26.99 for PE).
• Clinical notes detailing the patient's history, physical examination findings, and rationale for Xarelto.
• Results of diagnostic tests (e.g., echocardiogram, CT angiogram, D-dimer) confirming the diagnosis.
• Documentation of previous anticoagulant trials, if step therapy is applicable, including reasons for failure or contraindications to alternatives.
• National Drug Code (NDC) for the specific Xarelto product.

Addressing Denials and the Appeals Process

Prior authorization denials for Xarelto often stem from insufficient clinical documentation, failure to meet step therapy requirements, or non-adherence to Molina's specific medical policies. Upon receiving a denial, healthcare organizations should review the stated reason and initiate a formal appeal. The appeal process typically involves submitting additional clinical information or a letter of medical necessity to support the original request.

Peer-to-Peer Reviews

For complex cases or initial denials, a peer-to-peer (P2P) review can be an effective pathway. This involves a discussion between the prescribing clinician and a Molina Healthcare medical director or pharmacist. The P2P review allows for a direct clinical dialogue to clarify medical necessity and present additional patient-specific factors that may not have been fully captured in the initial documentation.

Leveraging ePA Technology for Efficiency

Modern ePA solutions integrate with EMRs like Epic Hyperspace or Cerner PowerChart, facilitating the electronic submission of Xarelto prior authorizations. These systems can transmit X12 278 transactions or NCPDP SCRIPT requests directly to payers, including Molina Healthcare. Adoption of the Da Vinci PAS implementation guide can further standardize data exchange and automate parts of the PA process, reducing manual effort and potential errors.

Compliance and Operational Best Practices

Maintaining compliance with HIPAA and other regulatory mandates is paramount when exchanging patient health information for prior authorizations. Organizations must ensure that ePHI is protected throughout the PA workflow, regardless of the submission method. Regular audits of PA processes and staff training on Molina-specific requirements can mitigate compliance risks and improve operational efficiency.